In this study, it was aimed to investigate whether there is a relationship between SGLT2 inhibitor use and the development of CIN in diabetic patients who underwent coronary angiography and/or percutaneous coronary intervention. The gene discussed is SLC5A2; the disease is cervical squamous intraepithelial neoplasia.